Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy
暂无分享,去创建一个
H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | T. Kadia | P. Jain | F. Ravandi | G. Borthakur | E. Jabbour | N. Daver | P. Boddu